CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Open-market sale Director sold 20,000 shares at $112.54 ($2,250,800)
- 8-K Event Results of operations
- 10-K Report Annual Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 1,200,000 shares at $105.47 ($126,564,000)
- 4 Open-market sale Director sold 1,200,000 shares at $105.47 ($126,564,000)
- 4/A Open-market sale Director sold 5,908 shares at $287.46 ($1,698,314)
- 8-K Event Material agreement
- 424B7 Offering Prospectus
- 8-K Event Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations
Page 26 of 62 · 1,224 filings